Clinical Trial Update: Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pitavastatin in hypercholesterolemic patients with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Metabolic Syndrome

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Aichi Gakuin University | Conditions: Metabolic Syndrome, Oxidative Stress | Phase 4 | Status: COMPLETED